COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

About Us

The Evolution of an Outsourcing Facility

KRS provides solutions in a challenging and changing environment that address savings initiatives, keeping abreast of the latest and greatest treatments and staying educated on the newest life-saving drug developments. KRS is first in keeping customers one step ahead of these challenges, and always placing patient safety, quality and efficiency first.

2019  

Cleveland Diabetes Care acquired 100% of KRS Biotechnology

2014 2015  

KRS Facilities Expansion

2013 2014  

KRS becomes an FDA Registered and Inspected Human Outsourcing Facility

2010  

Service Expansion to Include Chemotherapy & Veterinary/Equine Markets

2009 2010  

Pharmacy Operations Expand to Include Nearly Every State

2008  

KRS Focuses on Drug Shortages Affecting Hospitals & Surgical Centers

2001  

KRS Global Biotechnology Founded

World Class Products

At KRS, we understand that the quality of the products we manufacture directly affects the final consumer. We make no compromise; our processes implement the highest standards of quality control and testing equipment. On-site biochemists and microbiologists adhere to the strictest quality control measures, ensuring that your customers receive the highest quality services.

Our staff includes expert microbiologists, biochemists, chemists and PhDs.

Our Mission

Through our strong foundation and proven track record of success, by virtue of innovation and the development of new products and services, KRS Global Biotechnology is committed to being the preferred partner for our customers’ research, advanced analytical testing and product needs.

KRS—Your Outsourcing Partner

KRS commits to compliance with FDA guidelines and guidances. KRS commits to quality, patient safety, and setting the ethical standard for all other 503b outsourcing facilities. KRS is registered with the FDA as a DEA Manufacturer and holds State Board of Pharmacy licenses both in-state and out-of-state. KRS follows all applicable cGMP requirements and meets or exceeds USP Chapter <797> requirements. Our products are recognized as superior preparations due to our process validations that mirrors that of a pharmaceutical manufacturer. Our quality assurance mirrors that of a full analytical laboratory by providing certificates of analysis on all sterile preparations.

KRS is much more than just a supplier of sterile compounded products. The clinical pharmacists at KRS also provide guidance to their clients on the proper handling of sterile products, regulatory requirements regarding sterile products, and clinical expertise in the use of the products they prepare.

KRS pharmacists and staff are available to answer your questions, anytime! We are here to help you with timely answers to formulation questions, product availability, clinical assistance and anything else related to sterile injectable products.